Molecular Transfer Inc. Acquires GlobalStem - Expands into Stem Cell and Neuroscience Research Markets
News Apr 21, 2010
Molecular Transfer Inc. (MTI) is expanding into stem cell and neuroscience research markets through the acquisition of GlobalStem. The all-cash acquisition will allow MTI to strategically bring together both companies’ technologies and expertise to expand into these rapidly growing research areas.
GlobalStem, Inc. is known for high-quality standardized tools and reagents used in stem cell research and for its contract services to ensure the identity, stability and integrity of stem cell lines. The company’s sales are growing in excess of 50% annually. MTI has retained all of GlobalStem’s employees and their lab facilities and plans to expand the group to meet the strong projected growth and to provide support for their substantial customer base. Dr. Jonathan Auerbach, CEO of GlobalStem, will become President and CSO of MTI’s new GlobalStem division.
"Merging the two companies brings together proven experts in transfection, neurobiology and stem cell biology. This scientific expertise combined with MTI’s product development experience will allow MTI to provide novel solutions to the stem cell and neurobiology markets,” said Joel Jessee, CEO at MTI. “Our initial focus will be to leverage our proprietary transfection technology with stem cells, including reprogrammed stem cells, and introduce novel products, directly and through OEM relationships”.
Jonathan Auerbach added, “All of us at GlobalStem are excited about the opportunity to join MTI and grow our core business. The combined company’s ability to transfect various molecules into stem cells, primary cells and neuronal cells will be a valuable combination for our customers.”
The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.READ MORE